In the BioHarmony Drug Report Database
Fospropofol
Lusedra (fospropofol) is a small molecule pharmaceutical. Fospropofol was first approved as Lusedra on 2008-12-12. Lusedra’s patent is valid until 2022-07-01 (FDA).
Trade Name
|
Lusedra |
|---|---|
Common Name
|
fospropofol |
ChEMBL ID
|
CHEMBL1201766 |
Indication
|
|
Drug Class
|
Phosphoro-derivatives |
Image (chem structure or protein)